Cancer Gene Therapy Market : Market Growth, Size, Share, Trends, Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

31/mag/2018 09:46:25 rashmii Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Cancer Gene Therapy Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

Global Cancer Gene Therapy Market: Globally, rising cancer prevalence will increase demand for gene therapy as the effective personalized treatment choice. Various factors, such as the increase in the prevalence of cancer, rising government initiatives, increase in funding from various government and non-government organizations, ethical acceptance of gene therapy for treatment of diseases and growing popularity of DNA vaccines is driving the global cancer gene therapy market. However, less awareness and high cost involved in treatment, Lack of reimbursement policies for advanced gene therapy methods are restraining the growth of the global market for cancer gene therapy.


A sample of this report is available upon request @


The Global cancer gene therapy market is segmented on the basis of type, therapy, end-user and regional


Based on the type, global cancer gene therapy market is segmented as:

·         Gene Induced Immunotherapy

·         Tumour Antigen Gene Delivery

·         Cytokine Gene Delivery

·         Oncolytic Virotherapy

·         Adenoviruses

·         Adeno Associated Virus

·         Lentiviruses

·         Alpha Virus

·         Retrovirus

·         Herpes Simplex Virus

·         Vaccinia virus

·         Simian Virus

·         Gene Transfer/ Gene Replacement

·         Electroporation

·         Magnetofection

·         Naked / Plasmid Vectors

·         Gene Gun

·         Sonoporation


Based on the therapy, global cancer gene therapy market is segmented as:

·         Retroviral Therapy

·         Adenoviral Therapy


Based on the end-user, global cancer gene therapy market is segmented as:

·         Hospitals

·         Oncology institutes

·         Biotechnological companies

·         Clinical Research Labs


To view TOC of this report is available upon request @


Global cancer gene therapy market is highly fragmented with small biotech firms holding a chunk of the overall industry share. Major industry participants adopting various strategies to retaining their market positions such as the development of advanced technologies, maintaining a strong intellectual property, strategic collaborations, and joint ventures adopted by in the global cancer gene therapy. As per WHO, cancer incidence is projected to rise by 50% to reach 15 Mn by the end of this decade. This alarming increase in the number of patients and side effects associated with various chemotherapy drugs necessitates this as a potential treatment approach addressing the growing global burden of the cancers. Small biotech firms dominate the global cancer gene therapy market than the bigger players. The players are constantly engaged in R&D in order to develop novel methods to treat various life-threatening diseases. Increased in the adoption of emerging genomic technologies such as Next Generation Sequencing (NGS) and high-density microarray coupled with favorable government initiatives will fuel global cancer gene therapy market. For instance, CDC supports nationwide screening programs for control of breast, cervical and colorectal cancer among low-income women with little or no health insurance.


Need more information about this report @


Geographically, the cancer gene therapy is segmented into North America, Europe, Latin America, Asia- Pacific and the Middle East and Africa. North America leads the global cancer gene therapy market owing to the large pool of aging population and advancements in technology high investments in R & D activities along with the government support will boost industry demand. The U.K. market is anticipated to grow rapidly over the forecast period due to the rising occurrence of cancer along with the increase in acceptance of gene technology. Asia-Pacific is expected to witness high growth in cancer gene therapy market, due to increase in government initiatives, rising economy, and improvement in healthcare infrastructure in the region. Some of the key driving forces for cancer gene therapy market in emerging countries are increasing R&D investment, a large pool of patients and rising government funding.


Some of the major companies operating in the global cancer gene therapy market are Urigen Pharmaceuticals Inc. (U.S), GenVec.Inc (U.S), Oxford BioMedica (U.K),  Vical (U.S), ANI Pharmaceuticals, Inc. (U.S), and Genzyme Corporation (U.S). Novartis AG (Switzerland), and Cell Medica (U.K.)


Get access to full summary @


About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights


Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX


Toll Free (US): +1-866-598-1553

Website @



blog comments powered by Disqus è un servizio offerto da Factotum Srl